drugset / Trial / NCT03656666

The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus

NCT03656666

RandomizedParallel-groupTriple-blindTreatment

Summary

Genital erosive lichen planus (GELP) is a chronic inflammatory disease causing painful genital sores and scarring in women. Treatment options are limited and often unsatisfactory. This trial will study the effects of treatment with apremilast and quality of life and sexual function in women with GELP.

Timeline

Start
2019-09-24
Primary completion
2022-11-30
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Apremilast Small molecule 30 mg Oral